ANOVA analysis of the relationship between social deprivation quintile and clinical variables
| CTDPH | CTEPH | |||
| Data | p-value | Data | p-value | |
| Age at diagnosis years | 62.0±12 | 0.03 | 60.6±15.4 | 0.07 |
| Male % | 16.0 | 0.89 | 53.5 | 0.71 |
| BMI kg·m−2 | 26.9±7.2 | 0.76 | 28.4±6.2 | 0.046 |
| TLCO % pred | 37.3±15.6 | 0.45 | 60.9±19.6 | 0.04 |
| RAP mmHg | 8.1±5.8 | 0.53 | 7.7±5.9 | 0.43 |
| mPAP mmHg | 43.8±11.7 | 0.54 | 41.9±12 | 0.68 |
| PAWP mmHg | 8.3±4.7 | 0.03 | 8.7±4.1 | 0.41 |
| PVR WU | 10.8±5.6 | 0.78 | 9.2±4.9 | 0.07 |
| SvO2 % | 60.9±10.2 | 0.60 | 60.9±9.6 | 0.22 |
| Cardiac output L·min−1 | 3.8±1.2 | 0.52 | 4.0±1.2 | 0.07 |
| 6MWD m | 224±124 | 0.12 | 303±143 | <0.001 |
| NT-proBNP | 3340±4325 | 0.54 | 1679±2103 | 0.19 |
| emPHasis-10 | 33.0±11.9 | <0.001 | 31.8±11.6 | 0.006 |
| WHO FC III/IV % | 83.1 | 0.48 | 73.2 | 0.032 |
| PEA % | 42.6 | 0.46 | ||
Data are presented as mean±sd, unless otherwise stated. CTDPH: connective tissue disease-associated pulmonary hypertension; CTEPH: chronic thromboembolic pulmonary hypertension; BMI: body mass index; TLCO: transfer factor of the lung for carbon monoxide; RAP: right atrial pressure; mPAP: mean pulmonary arterial pressure; PAWP: pulmonary arterial wedge pressure; PVR: pulmonary vascular resistance; SvO2: mixed venous oxygen saturation; 6MWD: 6-min walk distance; NT-proBNP: N-terminal pro-brain natriuretic peptide; WHO FC: World Health Organization functional class; PEA: pulmonary endarterectomy.